Becker's Healthcare June 29, 2020
Laura Dyrda

Paul Rothman, MD, CEO of Baltimore-based Johns Hopkins Medicine and dean of the medical faculty at Johns Hopkins University, discussed the health system’s COVID-19 data platform and the potential for artificial intelligence to make a difference in how health systems approach treatment in the future in an interview with The Media Line.

Since the pandemic began, Johns Hopkins has gathered COVID-19 data and reported it on a public dashboard for cases and deaths in the U.S. and across the world. Dr. Rothman said the health system is using artificial intelligence and machine learning in its platform and aims to collaborate with others to incorporate data in the future.

One of the big questions Johns Hopkins hopes to address with additional...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Health System / Hospital, Pharma / Biotech, Physician, Precision Medicine, Provider, Technology
109 hospitals receiving new Medicare-backed residency slots
STAT+: UnitedHealth pays its own physician groups considerably more than others, driving up consumer costs and its profits
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Senators urge Congress to avert Medicare physician pay cut
New study offers insights into reliable Alzheimer's diagnosis

Share This Article